Tankyrase-1 mRNA expression in bladder cancer and paired urine sediment: preliminary experience.
about
para-Substituted 2-phenyl-3,4-dihydroquinazolin-4-ones as potent and selective tankyrase inhibitorsMolecular resistance fingerprint of pemetrexed and platinum in a long-term survivor of mesotheliomaGene expression levels of human shelterin complex and shelterin-associated factors regulated by the topoisomerase II inhibitors doxorubicin and etoposide in human cultured cells.Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study.XAV939, a tankyrase 1 inhibitior, promotes cell apoptosis in neuroblastoma cell lines by inhibiting Wnt/β-catenin signaling pathway.Tankyrases as drug targets.Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies.Tankyrases: structure, function and therapeutic implications in cancer.Design and Discovery of 2-Arylquinazolin-4-ones as Potent and Selective Inhibitors of Tankyrases.Tankyrase Requires SAM Domain-Dependent Polymerization to Support Wnt-β-Catenin Signaling.Intracellular distribution of Tankyrases as detected by multicolor immunofluorescence techniques.Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding.Wnt inhibitor XAV939 suppresses the viability of small cell lung cancer NCI-H446 cells and induces apoptosis.The binding mechanism of a novel nicotinamide isostere inhibiting with TNKSs: a molecular dynamic simulation and binding free energy calculation.Expression of tankyrase 1 in gastric cancer and its correlation with telomerase activity.Inhibitory effects of XAV939 on the proliferation of small-cell lung cancer H446 cells and Wnt/β-catenin signaling pathway in vitro.
P2860
Q27687215-AA2C7790-FE1A-4B51-B29D-0E16E86105DCQ28482133-224DD01F-4591-496F-876A-CD25E7AB61DDQ34514751-2FFCD994-17DA-453F-8A9C-082C321636B3Q35944928-8D98BD31-CB7E-4412-A352-7F570AA79DD4Q37400198-BD9D377C-A55F-4C4B-9C87-7F60AE89A83BQ38104494-DE047260-3C97-43D7-B1FF-2C7A1D626A24Q38216129-636C1238-C653-4CFF-92ED-E45090D79DE7Q38224266-884B91FF-932E-4A93-8676-39BA8F4DDEFEQ39780065-73EF42EE-646E-45C8-9871-24ACE84B46C2Q42365236-1CE3EC6E-FADD-4B43-A314-8312B21D1D83Q43172497-72481925-E8BD-4A84-8D0F-C49D74D3EDA2Q47131999-8E5C700E-FBC5-4E82-956C-06F58E2BFA81Q48533288-A1D8A307-FD74-4D31-A4CE-80384E3305C2Q50921784-B8B880EE-4BE8-458B-BC68-2DF49B2905F1Q54380017-585EAC8D-3F31-426C-B666-ADB7BCE97F63Q55643844-5F5AAED9-76C2-440A-95BB-DFC5C717D2DB
P2860
Tankyrase-1 mRNA expression in bladder cancer and paired urine sediment: preliminary experience.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Tankyrase-1 mRNA expression in ...... iment: preliminary experience.
@ast
Tankyrase-1 mRNA expression in ...... iment: preliminary experience.
@en
Tankyrase-1 mRNA expression in ...... iment: preliminary experience.
@nl
type
label
Tankyrase-1 mRNA expression in ...... iment: preliminary experience.
@ast
Tankyrase-1 mRNA expression in ...... iment: preliminary experience.
@en
Tankyrase-1 mRNA expression in ...... iment: preliminary experience.
@nl
prefLabel
Tankyrase-1 mRNA expression in ...... iment: preliminary experience.
@ast
Tankyrase-1 mRNA expression in ...... iment: preliminary experience.
@en
Tankyrase-1 mRNA expression in ...... iment: preliminary experience.
@nl
P2093
P2860
P356
P1476
Tankyrase-1 mRNA expression in ...... iment: preliminary experience.
@en
P2093
Alessandro Della Melina
Cesare Selli
Claudio Orlando
Donata Villari
Fabrizio Travaglini
Francesca Malentacchi
Gianluca Giannarini
Giulio Nicita
Mario Pazzagli
Silvia Quattrone
P2860
P304
P356
10.1515/CCLM.2007.133
P577
2007-01-01T00:00:00Z